First Eagle Investment Management
ITCI

First Eagle Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

First Eagle Investment Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-17,500
Closed -$295K – 351
2014
Q2 		$295K Buy
+17,500
New +$289K ﹤0.01% 254

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

First Eagle Investment Management's ITCI Position: Q3 2014 in Review

First Eagle Investment Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2014, closing a stake of 17,500 shares — an estimated $295K sold.

First Eagle Investment Management first reported a position in ITCI in Q2 2014 and held it in 1 quarter. The position peaked at $295K in Q2 2014. 49 funds tracked by Wall St. Rank hold ITCI as of Q3 2014.

  • First Eagle Investment Management reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2014 after selling out during the quarter.
  • First Eagle Investment Management sold 17,500 Intra-Cellular Therapies Inc. shares in Q3 2014, an estimated $295K.
  • First Eagle Investment Management first reported a position in Intra-Cellular Therapies Inc. in Q2 2014 and held it in 1 quarter.
  • First Eagle Investment Management's Intra-Cellular Therapies Inc. position peaked at $295K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2014.

Based on First Eagle Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.